Summary
Dr. Greg Dennis explores the therapeutic potential of high-dose vitamin C beyond the common cold, covering the differences between oral and intravenous forms of ascorbic acid. He discusses how vitamin C acts as an antioxidant at standard doses but can function as a pro-oxidant at high intravenous doses, which has implications for cancer treatment. The episode covers the pharmacokinetics of oral versus IV vitamin C, explaining that intravenous delivery achieves blood levels roughly 100 times higher than equivalent oral doses. Dennis reviews emerging research on IV vitamin C as an adjunct to chemotherapy, particularly for colorectal and pancreatic cancers, and discusses liposomal vitamin C as a middle ground between standard oral supplements and IV administration.
Key Points
- Vitamin C is an essential micronutrient that humans cannot synthesize and must obtain from diet or supplementation
- At normal dietary doses vitamin C acts as an antioxidant, but at high IV doses it becomes a pro-oxidant that can damage cancer cells
- Intravenous vitamin C achieves blood concentrations roughly 100 times higher than equivalent oral doses
- Liposomal vitamin C offers improved oral bioavailability compared to standard ascorbic acid supplements
- Emerging research shows IV vitamin C may enhance chemotherapy effectiveness for certain cancers including colorectal and pancreatic
- The body has a saturation limit for oral vitamin C absorption through the intestines, making IV the only way to reach therapeutic doses
- Vitamin C plays a role in collagen synthesis, immune function, and as a cofactor in numerous enzymatic reactions
Key Moments
Different forms and delivery methods of vitamin C
Dr. Dennis explains there are many more health benefits to vitamin C than most people realize, and that different forms and higher doses unlock therapeutic potential beyond basic supplementation.
"But there's much, much more to it than that, as I have recently learned, and especially using some higher doses of vitamin C. But also there's different forms of vitamin C, which we're going to talk about."
IV vitamin C achieves far higher blood levels than oral
The episode explains the critical pharmacokinetic difference between oral and intravenous vitamin C, with IV delivery achieving roughly 100 times higher blood concentrations than equivalent oral doses.
"these services and therapeutic administration of vitamin C for infection, to treat infections and ultimately as well as cancer. Little did we know that when we developed it, that we are going to have a close call with that and we were also going to become patients. And so my husband at that time was diagnosed with the second most aggressive form of cancer,"
Liposomal vitamin C as a middle ground
Dr. Dennis discusses liposomal vitamin C as an option that offers improved oral bioavailability compared to standard ascorbic acid, bridging the gap between regular supplements and IV administration.
"Now, whether they did the studies correctly or not, that's a different discussion. But there's close to 80,000 articles on vitamin C on PubMed alone. And this has been going on from 1928 when San Giorgi actually discovered what we know today as ascorbic acid, which is the common term of vitamin C."
